Stefan Vaughn

Vice President, Chief Financial Officer

Stefan Vaughn is responsible for leadership and oversight of the finance function and related processes for the US organization.

Stefan has nearly 20 years of finance experience in manufacturing, consumer goods, biopharmaceuticals, and consulting. He has held successive leadership roles in US and international commercial finance, including as Asia Pacific CFO for Takeda Pharmaceuticals, a $1 billion business. At Takeda, he supported the business transformation of commercial operations, business development, ERP implementation programs, and global operational efficiency initiatives designed to reduce duplication and complexity.

Prior to Takeda, Stefan worked for Robert Bosch Tool Corporation, CF Industries and McBee Associates in various finance positions.

He holds a Masters of Business Administration from DePaul University and a Bachelor’s of Science in Finance from University of Maryland.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028